Medtronic Goodwill and Intangible Assets 2010-2025 | MDT
Medtronic goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- Medtronic goodwill and intangible assets for the quarter ending January 31, 2025 were $53.003B, a 3.37% decline year-over-year.
- Medtronic goodwill and intangible assets for 2024 were $54.211B, a 3.66% decline from 2023.
- Medtronic goodwill and intangible assets for 2023 were $56.269B, a 0.31% increase from 2022.
- Medtronic goodwill and intangible assets for 2022 were $56.097B, a 6.04% decline from 2021.
| Medtronic Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $54,211 |
| 2023 | $56,269 |
| 2022 | $56,097 |
| 2021 | $59,701 |
| 2020 | $58,904 |
| 2019 | $60,519 |
| 2018 | $61,266 |
| 2017 | $61,922 |
| 2016 | $68,399 |
| 2015 | $68,631 |
| 2014 | $12,879 |
| 2013 | $13,002 |
| 2012 | $12,581 |
| 2011 | $12,245 |
| 2010 | $10,950 |
| 2009 | $10,672 |
| Medtronic Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2025-01-31 | $53,003 |
| 2024-10-31 | $53,584 |
| 2024-07-31 | $53,903 |
| 2024-04-30 | $54,211 |
| 2024-01-31 | $54,850 |
| 2023-10-31 | $54,881 |
| 2023-07-31 | $55,870 |
| 2023-04-30 | $56,269 |
| 2023-01-31 | $56,830 |
| 2022-10-31 | $56,072 |
| 2022-07-31 | $56,099 |
| 2022-04-30 | $56,097 |
| 2022-01-31 | $57,424 |
| 2021-10-31 | $58,135 |
| 2021-07-31 | $58,610 |
| 2021-04-30 | $59,701 |
| 2021-01-31 | $60,381 |
| 2020-10-31 | $59,624 |
| 2020-07-31 | $59,384 |
| 2020-04-30 | $58,904 |
| 2020-01-31 | $59,547 |
| 2019-10-31 | $59,727 |
| 2019-07-31 | $60,316 |
| 2019-04-30 | $60,519 |
| 2019-01-31 | $60,838 |
| 2018-10-31 | $59,424 |
| 2018-07-31 | $60,225 |
| 2018-04-30 | $61,266 |
| 2018-01-31 | $61,973 |
| 2017-10-31 | $61,702 |
| 2017-07-31 | $62,202 |
| 2017-04-30 | $61,922 |
| 2017-01-31 | $67,433 |
| 2016-10-31 | $68,446 |
| 2016-07-31 | $67,746 |
| 2016-04-30 | $68,399 |
| 2016-01-31 | $67,692 |
| 2015-10-31 | $69,005 |
| 2015-07-31 | $68,356 |
| 2015-04-30 | $68,631 |
| 2015-01-31 | $13,289 |
| 2014-10-31 | $13,461 |
| 2014-07-31 | $13,037 |
| 2014-04-30 | $12,879 |
| 2014-01-31 | $12,965 |
| 2013-10-31 | $13,072 |
| 2013-07-31 | $12,953 |
| 2013-04-30 | $13,002 |
| 2013-01-31 | $13,099 |
| 2012-10-31 | $12,444 |
| 2012-07-31 | $12,492 |
| 2012-04-30 | $12,581 |
| 2012-01-31 | $12,628 |
| 2011-10-31 | $12,819 |
| 2011-07-31 | $12,236 |
| 2011-04-30 | $12,245 |
| 2011-01-31 | $12,286 |
| 2010-10-31 | $11,197 |
| 2010-07-31 | $10,905 |
| 2010-04-30 | $10,950 |
| 2010-01-31 | $10,519 |
| 2009-10-31 | $10,596 |
| 2009-07-31 | $10,634 |
| 2009-04-30 | $10,672 |
| 2009-01-31 | $9,930 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $107.169B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||